In light of recent developments, has your hospital's P&T or ID committee
considered reviewing alternatives to pyrimethamine (Daraprim) for toxoplasmosis?
Sincerely,
Sudha
--
Sudha Narayanaswamy, PharmD, BCPP, CGP
Vice President, Clinical Pharmacy Program
GNYHA Services, Inc. | 555 W. 57th Street, 11th Floor | New York, NY 10019
o: 212-258-5376 | f: 212-541-9032 | E-mail:
snarayanaswamy@xxxxxxxxx<mailto:snarayanaswamy@xxxxxxxxx>
Website: Http://pharmacy.gnyhaservices.com<http://pharmacy.gnyhaservices.com/>